Merck reports strong new HIV study results showing non-inferiority of DOR/ISL to Gilead's Biktarvy and secures an EU approval ...

United Therapeutics' stock surged after IPF trial results and what future pivotal trials could mean for investors. See here ...

Malawi's war against malaria has received a powerful new weapon following the World Health Organization's approval of the first-ever child-friendly, transmission-blocking formulations of primaquine.

Tonix Pharma announces US commercial availability of Tonmya as a first-in-class fibromyalgia treatment: Chatham, New Jersey Thursday, November 20, 2025, 17:00 Hrs [IST] Tonix Phar ...

During the past few years, NSS has sought to make itself responsive to emerging data needs. As NSS celebrates its 75th year, ...

AIOCD asks traders to strictly comply with the ban on 35 FDCs: Peethaambaran Kunnathoor, Chennai Friday, November 21, 2025, ...

The emerging prevalence of digitalization is a key topic for manufacturers handling excipients. Digital transformation and data integrity protocols are crucial strategies for optimizing drug ...

VANCOUVER, BC / ACCESS Newswire / November 20, 2025 /BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery ...

VANCOUVER, BC / ACCESS Newswire / November 20, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery ...

"Cinclus Pharma has now entered late-stage clinical development following the initiation of its first Phase III study, and patient recruitment has so far progressed well. Topline results are expected ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...